Sudeep Pharma Limited (NSE:SUDEEPPHRM)

Sudeep Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2004
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2004
Cash & Equivalents	674.78	368.07	139.76	103.01	214.74	0.03
Short-Term Investments	1.41	150	-	-	-	-
Trading Asset Securities	-	1.36	1.27	30.33	-	-
Cash & Short-Term Investments	676.19	519.43	141.03	133.34	214.74	0.03
Cash Growth	379.47%	268.32%	5.77%	-37.91%	654176.23%	45.09%
Accounts Receivable	2,007	1,854	1,446	937.12	1,066	24.62
Other Receivables	-	313.39	231.64	320.71	111.51	-
Receivables	2,008	2,170	1,690	1,268	1,185	24.62
Inventory	1,844	1,287	665.82	709.97	365.35	3.01
Prepaid Expenses	-	88.32	18.51	13.73	4.98	-
Other Current Assets	859.84	176.82	237.86	175.58	191.77	4.19
Total Current Assets	5,388	4,241	2,754	2,300	1,962	31.86
Property, Plant & Equipment	3,643	2,773	2,246	1,838	1,459	27.57
Long-Term Investments	-	3.33	3.2	2.05	1.94	0.1
Other Intangible Assets	1.64	2.1	3.02	3.95	-	-
Long-Term Deferred Tax Assets	2.68	3.25	2.28	5.44	4.74	-
Other Long-Term Assets	234.52	148.43	130.62	51.49	22.88	-
Total Assets	9,880	7,172	5,139	4,201	3,450	59.53
Accounts Payable	729.63	604.8	507.1	384.96	305.54	9.55
Accrued Expenses	-	47.85	40.71	514.57	578.16	-
Short-Term Debt	-	654.9	548.3	518.17	484.8	11.2
Current Portion of Long-Term Debt	1,066	302.11	97.16	104.97	70	-
Current Portion of Leases	4.81	6.44	7.51	2.86	2.2	-
Current Income Taxes Payable	83.16	27.88	1.72	20.04	9.66	-
Other Current Liabilities	159.36	103.59	170.11	162.72	24.83	5.24
Total Current Liabilities	2,043	1,748	1,373	1,708	1,475	25.98
Long-Term Debt	342.2	395.53	111.43	199.41	282.34	11.56
Long-Term Leases	14.26	16.55	22.99	5.42	8.28	-
Pension & Post-Retirement Benefits	-	2.9	3.94	-	2.12	-
Long-Term Deferred Tax Liabilities	74.01	63.59	58.47	51.33	48.48	1.84
Other Long-Term Liabilities	19.58	14.64	9.27	3.83	5.54	-
Total Liabilities	2,493	2,241	1,579	1,968	1,822	39.38
Common Stock	97.23	97.23	14.09	14.09	14.09	12.68
Additional Paid-In Capital	-	-	98.56	98.56	98.56	-
Retained Earnings	-	4,856	3,478	2,150	1,527	7.47
Comprehensive Income & Other	7,146	-21.85	-30.74	-30.08	-11.18	-
Shareholders' Equity	7,387	4,931	3,560	2,233	1,628	20.15
Total Liabilities & Equity	9,880	7,172	5,139	4,201	3,450	59.53
Total Debt	1,427	1,376	787.39	830.83	847.62	22.76
Net Cash (Debt)	-751.02	-856.1	-646.37	-697.49	-632.88	-22.73
Net Cash Per Share	-6.92	-7.89	-5.96	-6.43	-5.83	-0.97
Filing Date Shares Outstanding	108.92	97.23	31	1.41	1.41	27.9
Total Common Shares Outstanding	108.92	97.23	31	1.41	1.41	27.9
Working Capital	3,345	2,494	1,381	591.89	486.41	5.88
Book Value Per Share	66.50	50.72	114.84	1584.59	1155.38	0.72
Tangible Book Value	6,632	4,929	3,557	2,229	1,628	20.15
Tangible Book Value Per Share	60.89	50.69	114.74	1581.79	1155.38	0.72
Land	-	133.17	132.89	131.5	68.48	2.44
Buildings	-	896.82	840.79	702.97	684.18	11.89
Machinery	-	875.05	783.77	652.02	467.49	27.57
Construction In Progress	-	882.17	446.61	259.72	81.27	-
Leasehold Improvements	-	30.76	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.